CN1060391C - Traditional Chinese medicine for treating gynecological tumour - Google Patents
Traditional Chinese medicine for treating gynecological tumour Download PDFInfo
- Publication number
- CN1060391C CN1060391C CN97126195A CN97126195A CN1060391C CN 1060391 C CN1060391 C CN 1060391C CN 97126195 A CN97126195 A CN 97126195A CN 97126195 A CN97126195 A CN 97126195A CN 1060391 C CN1060391 C CN 1060391C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- radix
- medicine
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 55
- 206010028980 Neoplasm Diseases 0.000 title description 6
- 208000009849 Female Genital Neoplasms Diseases 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- 241000202807 Glycyrrhiza Species 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 240000005001 Paeonia suffruticosa Species 0.000 abstract description 2
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 210000000952 spleen Anatomy 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000002045 Guettarda speciosa Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 241000736199 Paeonia Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract 1
- 244000223014 Syzygium aromaticum Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 206010046798 Uterine leiomyoma Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 3
- 238000007596 consolidation process Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 208000025661 ovarian cyst Diseases 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical group COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000005220 pharmaceutical analysis Methods 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a traditional Chinese medicine for treating gynecological tumor, which is characterized in that the traditional Chinese medicine is prepared from the Chinese herbal medicines of astragalus root, largehead atractylodes rhizome, dried tangerine peel, cornel, matrimony vine, tuckahoe, clove, common aucklandia root, cassia bark, red peony root, peach seed, tree peony bark, motherwort, angelica, common prism tuber, zedoray rhizome, liquorice, etc. The components of the traditional Chinese medicine are soft in medicinal property, and the traditional Chinese medicine conforms to the theory of traditional Chinese medicine and pharmacy. The components of the traditional Chinese medicine can take the effects of strengthening the spleen, tonifying the kidney, regulating qi for activating stagnancy and activating blood circulation to disperse stasis. The Chinese patent medicine of the present invention has the advantages of treatment of both manifestation and root causes of gynecological tumor, convenience for taking, no toxic or side effect, therapeutic effect strengthening and high effective rate of 97.3%.
Description
The invention belongs to the medicine of treatment gynecological tumor, be specifically related to a kind of Chinese patent medicine for the treatment of gynecological tumor.
Gynecological tumor belongs to traditional Chinese medical science “ WEIJIA by its clinical symptoms " category, in all women's hypogastric region caking is arranged, or accompany distending pain person all to belong to this disease, press the modern medicine notion, comprise diseases such as hysteromyoma, ovarian cyst and cervical cancer.The primary disease sickness rate accounts for more than 1/2 of gynaecopathia, and is wherein the highest with the Uterine myomas rate especially, and according to statistics, the women more than 35 years old about 20% suffers from this disease, very big to WomanHealth harm.Doctor trained in Western medicine generally adopts operative therapy, but is difficult to eradicate, and relapse rate is higher; And the traditional Chinese medical science is all treated by the stagnation of QI, blood stasis or spleen kidney deficiency at present, in treatment, generally emphasizes promoting blood circulation to remove obstruction in the collateral, dissolving lump and resolving mass, though can receive certain curative effect, because patient's body constitution difference, curative effect can not be consolidated.
The Chinese medicine of the treatment gynecological tumor that purpose of the present invention aims to provide a kind of taking convenience, efficacy consolidation, have no side effect.
The solution that realizes above-mentioned purpose is based on pathogenetic understanding and the Therapeutic Principle of Chinese medicine to gynecological tumor, on the secret prescription handed down in the family from generation to generation basis, again through clinical research for many years, from motherland's medical treasure-house, filter out tonifying speen and tonifying kidney, regulating qi-flowing for activating stagnancy, the Chinese herbal medicine of blood circulation promoting and dispersing pathogen accumulation, by traditional Chinese medical science prescription theory, make oral Chinese patent medicine.
The traditional Chinese medical science is thought ， ” WEIJIA " generation relevant more than deficiency of vital QI, vim and vigour imbalance.It will be argued that it is all long that the women suffers from this sick stadium, eipathia asthenia person number in the majority, thus should not use the product of breaking through in a large number, and should adopt the method for the treatment of both the principal and secondary aspects of a disease, reinforcement and elimination in combination can be received good effect.Therefore, it is the principles of formulating prescriptions that the inventor proposes with " tonifying speen and tonifying kidney, regulating qi-flowing for activating stagnancy, blood circulation promoting and dispersing pathogen accumulation ", meets the etiology and pathogenesis of primary disease.
The raw material of Chinese medicine of Chinese patent medicine of the present invention and weight proportion are:
The Radix Astragali 27-33 Rhizoma Atractylodis Macrocephalaes 13-17 Pericarpium Citri Reticulataes 13-17 Fructus Corni 8-12
Fructus Lycii 8-10 Poria 18-22 Flos Caryophyllis 4-6 Radix Aucklandiae 7-9
Cortex Cinnamomi 7-9 Radix Paeoniae Rubra 13-17 Semen Persicaes 8-12 Cortex Moutans 18-22
Herba Leonuri 13-17 Radix Angelicae Sinensis 13-17 rhizoma sparganic 5-7 Rhizoma Curcumae 5-7 Radix Glycyrrhizaes 5-7
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
Pharmaceutical analysis:
The Radix Astragali in the side, the Rhizoma Atractylodis Macrocephalae are invigorating QI to consolidate the body surface resistance, tonifying speen and tonifying kidney function; The product that Poria, Pericarpium Citri Reticulatae are good for the stomach for regulating the flow of vital energy, and the promoting diuresis to eliminate damp pathogen effect is arranged; Fructus Corni, Fructus Lycii are the product of nourishing the liver and kidney, can increase body resistance against diseases, and the opposing exopathogen is invaded human body; Flos Caryophylli, the Radix Aucklandiae, Cortex Cinnamomi all contain volatile oil, and the analgesic effect of dispersing is arranged, and whole Chinese medicines are played one's part to the full infiltrate the human efficiency; Radix Angelicae Sinensis, Semen Persicae, Herba Leonuri are the key medicines of invigorating blood circulation of enriching blood, and promote the blood of human body circulation, remove lump, and Cortex Moutan is the product of blood circulation promoting competent silt, and its active ingredient of modern study is paeonol and Paeonia suffruticosa glycoside, antiinflammatory is arranged and eliminate function of tumor; Rhizoma sparganic, Rhizoma Curcumae are the traditional medicine for treating tumor thing of the traditional Chinese medical science, and the removing blood stasis effect of invigorating blood circulation is arranged; Radix Glycyrrhizae has the blending effect to all medicines.Full side's compatibility, to improve the body resistivity, an amount of on this basis adapted is eliminated the medicine of tumor, reaches the purpose for the treatment of both the principal and secondary aspects of a disease.Full presciption medicine is gentle, meets Chinese medical theory.
Efficacy analysis: this medicine is mainly used in treatment gynecological benign tumor.It is as follows to add up 300 routine curative effects:
| Recovery from illness | Effectively | Invalid | Subtotal | |
| Hysteromyoma | 86 | 92 | 4 | 182 |
| Ovarian cyst | 17 | 19 | 2 | 38 |
| Cyclomastopathy | 30 | 34 | 0 | 64 |
| Other | 6 | 8 | 2 | 16 |
| Amount to | 139 46．3％ | 153 (51％) | 8 (2．7％) | 300 |
Above total effective rate is 97.3%, and wherein cure rate is 46.3%, and effective percentage is 51%, and inefficiency is 2.7%.
Model case:
Example one, Wu Chunmei, the woman 47 years old, lives Kun district, Baotou plant area of Baogang 33 * 30.
The year before because of abdominal pain, menorrhagia, and lump is arranged, hysteromyoma is confirmed as in ultrasound diagnosis through municipal hospital, and tumor body 1.4cm * 2.0cm because of the patient is reluctant operation, once obeyed Western medicine hormone and anthemorrhagic drug therapy, but effect is undesirable.Come institute treatment April 23 nineteen ninety-five, give Chinese patent medicine of the present invention at once, every day twice, each two balls, take medicine hemorrhagely stopped in 10 days substantially, continued to take medicine two and treated Cheng journey (40 days), and patient's symptom is all eliminated.The B ultrasonic check, lump disappears, and efficacy consolidation half a year is followed up a case by regular visits in patient's recovery from illness.
Example two, Yue Xiuying, the woman 63 years old, lives street outside the Donghe District south gate, Baotou.
The bimester cause suffer from ovarian cyst at certain large hospital hospitalization, once with several different methods such as radiotherapy and chemotherapy,, can not continue treatment because of patient's body constitution fails day by day, transferred my institute on the 8th in JIUYUE in 1994 and require to use treatment by Chinese herbs.It is simple and unadorned to look into patient's pale complexion, and appetite is poor, and abdominal mass can touch, obvious constriction is arranged, and edema of lower limbs is advised inactive Western medicine, use Chinese patent drugs for treatment of the present invention instead, every day twice, obey two balls at every turn, take medicine after the course of treatment, patient's symptom is obviously improved, and appetite increases, abdominal pain alleviates, and takes medicine 40 days again, and abdominal mass disappears substantially, symptom takes a turn for the better, can orthobiosis, obtain satisfactory effect.
Can find out from above-mentioned pharmaceutical analysis, efficacy analysis and model case, the present invention meets the generation and the law of development of gynecological tumor, treating both the principal and secondary aspects of a disease, taking convenience has no side effect, efficacy consolidation, effective percentage reaches 97.3%, full side's compatibility reaches the effect of " tonifying speen and tonifying kidney, regulating qi-flowing for activating stagnancy, blood circulation promoting and dispersing pathogen accumulation ".
Embodiment one, and the weight proportion of the raw material of Chinese medicine of Chinese patent medicine of the present invention is:
The Radix Astragali 30 Rhizoma Atractylodis Macrocephalaes 15 Pericarpium Citri Reticulataes 15 Fructus Corni 10
Fructus Lycii 9 Poria 20 Flos Caryophyllis 5 Radix Aucklandiae 8
Cortex Cinnamomi 8 Radix Paeoniae Rubra 15 Semen Persicaes 10 Cortex Moutans 20
Herba Leonuri 15 Radix Angelicae Sinensis 15 rhizoma sparganic 6 Rhizoma Curcumae 6 Radix Glycyrrhizaes 6
Method for making: above-mentioned ten seven flavor medicines, choose decontamination earlier, well sifted, pulverization is mixed well with equivalent Mel, makes big honeyed pills, and every ball weighs 9 grams.The honeyed pill quality should meet " the medicine pill standard of Chinese pharmacopoeia regulation.
Instructions about how to take medicine: obey twice for each person every day, each two balls, warm water send down, and weakling's consumption cuts down according to the circumstance.Medication 20 days was a course of treatment.
Embodiment two, and the weight proportion of the raw material of Chinese medicine of Chinese patent medicine of the present invention is:
The Radix Astragali 27 Rhizoma Atractylodis Macrocephalaes 13 Pericarpium Citri Reticulataes 13 Fructus Corni 8
Fructus Lycii 8 Poria 18 Flos Caryophyllis 4 Radix Aucklandiae 7
Cortex Cinnamomi 7 Radix Paeoniae Rubra 13 Semen Persicaes 8 Cortex Moutans 18
Herba Leonuri 13 Radix Angelicae Sinensis 13 Rhizoma Sparganii 5 Rhizoma Curcumae 5 Radix Glycyrrhizaes 5 are made oral Chinese patent medicine with above-mentioned Chinese medicine raw materials by weight proportion.Embodiment three, and the weight proportion of the raw material of Chinese medicine of Chinese patent medicine of the present invention is:
The Radix Astragali 33 Rhizoma Atractylodis Macrocephalaes 17 Pericarpium Citri Reticulataes 17 Fructus Corni 12
Fructus Lycii 10 Poria 22 Flos Caryophyllis 6 Radix Aucklandiae 9
Cortex Cinnamomi 9 Radix Paeoniae Rubra 17 Semen Persicaes 12 Cortex Moutans 22
Herba Leonuri 17 Radix Angelicae Sinensis 17 rhizoma sparganic 7 Rhizoma Curcumae 7 Radix Glycyrrhizaes 7
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
Claims (2)
1, the Chinese medicine of treatment gynecological tumor, it is characterized in that: raw material of Chinese medicine and weight proportion are:
The Radix Astragali 27-33 Rhizoma Atractylodis Macrocephalaes 13-17 Pericarpium Citri Reticulataes 13-17 Fructus Corni 8-12
Fructus Lycii 8-10 Poria 18-22 Flos Caryophyllis 4-6 Radix Aucklandiae 7-9
Cortex Cinnamomi 7-9 Radix Paeoniae Rubra 13-17 Semen Persicaes 8-12 Cortex Moutans 18-22
Herba Leonuri 13-17 Radix Angelicae Sinensis 13-17 rhizoma sparganic 5-7 Rhizoma Curcumae 5-7 Radix Glycyrrhizaes 5-7
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
2, the Chinese medicine of treatment gynecological tumor according to claim 1 is characterized in that: the weight proportion of the raw material of Chinese medicine of described Chinese patent medicine is:
The Radix Astragali 30 Rhizoma Atractylodis Macrocephalaes 15 Pericarpium Citri Reticulataes 15 Fructus Corni 10
Fructus Lycii 9 Poria 20 Flos Caryophyllis 5 Radix Aucklandiae 8
Cortex Cinnamomi 8 Radix Paeoniae Rubra 15 Semen Persicaes 10 Cortex Moutans 20
Herba Leonuri 15 Radix Angelicae Sinensis 15 rhizoma sparganic 6 Rhizoma Curcumae 6 Radix Glycyrrhizaes 6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97126195A CN1060391C (en) | 1997-12-31 | 1997-12-31 | Traditional Chinese medicine for treating gynecological tumour |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97126195A CN1060391C (en) | 1997-12-31 | 1997-12-31 | Traditional Chinese medicine for treating gynecological tumour |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1192364A CN1192364A (en) | 1998-09-09 |
| CN1060391C true CN1060391C (en) | 2001-01-10 |
Family
ID=5177592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97126195A Expired - Fee Related CN1060391C (en) | 1997-12-31 | 1997-12-31 | Traditional Chinese medicine for treating gynecological tumour |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1060391C (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1092972C (en) * | 2000-09-08 | 2002-10-23 | 沈汉澄 | Medicine for resisting tumor and carcinomatosis |
| EP2073825B1 (en) * | 2006-10-18 | 2017-04-05 | Jiangsu Kanion Pharmaceuticals Co. Ltd. | Cinnamomi and poria composition and uses thereof |
| CN103212022A (en) * | 2013-04-02 | 2013-07-24 | 成都科创佳思科技有限公司 | Chinese patent medicament for treating scars |
| CN103494985B (en) * | 2013-10-11 | 2015-07-08 | 刘正菊 | Externally applied patch for treating gynecological myoma of uterus and ovarian cyst |
| CN105012853A (en) * | 2014-04-16 | 2015-11-04 | 李冬华 | Traditional Chinese medicine composition for treating hysteromyoma, preparation method and uses thereof |
| CN105031552A (en) * | 2015-09-14 | 2015-11-11 | 李万青 | Traditional Chinese medicine composition for treating gynecological tumors |
| CN105727197A (en) * | 2016-04-01 | 2016-07-06 | 广州暨南生物医药研究开发基地有限公司 | Pharmaceutical composition containing folium artemisiae argyi for treating myoma of uterus and preparing method thereof |
| CN105999100A (en) * | 2016-07-05 | 2016-10-12 | 缪建林 | Formula for treating hysteromyoma |
| CN110279833B (en) * | 2019-06-18 | 2022-04-22 | 南京市浦口医院 | Traditional Chinese medicine composition for treating gynecological tumor and preparation method and application thereof |
-
1997
- 1997-12-31 CN CN97126195A patent/CN1060391C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 湖北中医杂志1984(5) 1984.1.1 周容华，加减少腹逐淤汤治愈子宫肌瘤4例 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1192364A (en) | 1998-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102727832B (en) | Chinese medicinal preparation for treating breast diseases and uterine fibroid and preparation method thereof | |
| CN102872418A (en) | Medicine for treating pelvic inflammation | |
| CN103263659B (en) | Traditional Chinese medicine composition for treating rheumatism bone diseases | |
| CN1060391C (en) | Traditional Chinese medicine for treating gynecological tumour | |
| CN102363020B (en) | Chinese medicinal composition for treating proliferation of mammary gland | |
| CN1486740A (en) | Chinese medicine composition for treating cancer | |
| CN101002873B (en) | Medicine for treating recurrent gout, and its preparing method | |
| CN1231252C (en) | Medicine for treatnig ovarian cyst | |
| CN101745047A (en) | Chinese medicinal composition for treating gout disease and preparation method thereof | |
| CN101002848B (en) | Medicine for treating recurrent uarthritis, and its preparing method | |
| CN103211886A (en) | Medicament for treating rheumatic arthritis | |
| CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN1332702C (en) | Medicine for treating psoriasis | |
| CN1253196C (en) | Medicine for treating colitis | |
| CN101164593A (en) | Oral liquid for treating kidney disease | |
| CN102688434A (en) | Traditional Chinese medicine (TCM) for treating diabetes | |
| CN1186083C (en) | Chinese medicine for treating mammary gland foliole proliferation | |
| CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN1181879C (en) | Analgestic plaster | |
| CN1116050C (en) | Medicine bolus for dredging meridian passage, nourishing blood and removing toxic material | |
| CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
| CN104288597A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN103316133B (en) | Medicine for treating lame impediment | |
| CN103071079A (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN109985208B (en) | Traditional Chinese medicine composition of lump relieving plaster |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |